Medical device makers IPO plans signal upturn in flat listings market

Q: How long will it take to read this news story?

The story "Medical device makers IPO plans signal upturn in flat listings market" has 600 words across 25 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Medical device makers IPO plans signal upturn in flat listings market" was covered 13 hours ago by Financial Times, a news publisher based in United States.

Q: How trustworthy is 'Financial Times' news outlet?

Financial Times is a fully independent (privately-owned) news outlet established in 1888 that covers mostly markets, finance, and investing news. The outlet is headquartered in United States and publishes an average of 6 news stories per day. It's most recent story was published 11 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25248442</li><li>URL: https://beamstart.com/news/medical-device-makers-ipo-plans-17372833371399</li></ul>

Financial Times 13h ago

Medical device makers IPO plans signal upturn in flat listings market - Financial Times

Quick Summary:

Along with Bain, Kestra is backed by T Rowe Price and Omega Funds, while Heartflow’s investors also include Baillie Gifford and Wellington Management.

Heartflow’s lead product is the first non-invasive device that can be used to diagnose coronary artery disease, which affects about 16mn Americans, according to official estimates.

Between the start of 2020 and the end of 2021, 16 companies went public in the US, compared with just four companies over the following three years, according to Dealogic.